GlassScriptPhysician profile
Rex A Sherer
NPI 1285608588
$4,363.45
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $57.27 · 2021: $3,629 · 2022: $109 · 2023: $210 · 2024: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,818.93 | 2019-2021 | |
| Ethicon US, LLC | $137.20 | 2019-2024 | Echelon; Endopath, Surgicel Nu-Knit, Vistaseal |
| Urgo Medical North America, LLC | $78.22 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Kowa Pharmaceuticals America, INC. | $72.67 | 2022-2023 | Seglentis, Livalo |
| Conmed Corporation | $66.50 | 2022-2024 | Airseal |
| Tela Bio, INC. | $48.78 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $37.24 | 2022-2024 | Integra, Omnigraft, Surgimend |
| Medtronic, INC. | $23.76 | 2022 | |
| Bioventus LLC | $22.15 | 2022 | |
| Standard Bariatrics, INC. | $20.00 | 2021 | |
| Innocoll Pharmaceuticals Limited | $19.79 | 2021 | |
| Heron Therapeutics, INC. | $18.21 | 2023 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Sherer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.